Bioforce Nanosciences Holdings (BFNH) Retained Earnings (2020 - 2026)

Bioforce Nanosciences Holdings has disclosed Retained Earnings across 7 years of filings, most recently posting -$162.5 million for Q1 2026.

• Quarterly Retained Earnings changed 0.28% year-over-year to -$162.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$162.5 million (changed 0.28% YoY) and the FY2025 annual result came in at -$162.4 million, down 0.8% from the prior year.
• Retained Earnings steadied at -$162.5 million in Q1 2026, from -$162.4 million in the prior quarter.
• Over five years, Retained Earnings peaked at -$159.8 million in Q1 2022 and troughed at -$162.5 million in Q1 2026.
• A 5-year average of -$161.0 million and a median of -$160.8 million in 2024 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2025 — Retained Earnings fell 0.81% — and 2026, when it fell 0.28%.
• Tracing BFNH's Retained Earnings over 5 years: stood at -$160.2 million in 2022, then slipped by 0.29% to -$160.6 million in 2023, then decreased by 0.31% to -$161.1 million in 2024, then dropped by 0.8% to -$162.4 million in 2025, then slipped by 0.06% to -$162.5 million in 2026.
• Business Quant data shows BFNH's Retained Earnings at -$162.5 million in Q1 2026, -$162.4 million in Q4 2025, and -$162.3 million in Q3 2025.